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Junctional epidermolysis bullosa, non-Herlitz (JEB-
nH) is an autosomal recessive EB subtype caused by 
mutations in the genes LAMA3, LAMB3, LAMC2 or 
COL17A1. The first three genes encode for laminin α3, 
laminin β3, and laminin γ2, respectively, which together 
form the heterotrimer laminin-332 (LM-332), whereas 
COL17A1 encodes for the homotrimer type XVII col-
lagen (Col17) (1). LM-332 and Col17 are located in the 
lamina basale, and are important in epidermal–dermal 
adhesion. JEB-nH shows blistering after minor trauma, 
but also extracutaneous symptoms, such as dental ab-
normalities (1). Both LM-332 and Col17 are crucial in 
ameloblast differentiation and enamel formation (2, 3), 
resulting in enamel defects of the entire dentition in all 
patients with JEB-nH, consisting of hypoplasia, pitting, 
roughness, thinning or furrowing of enamel (4). In 1996, 
McGrath et al. (5) reported the first heterozygous carriers 
of a COL17A1 mutation with enamel defects. The carriers 
of the glycine substitution p.G627V had no signs of skin 
fragility, but did have extensive enamel hypoplasia and 
pitting, thought to be caused by the dominant-negative 
effect of the mutant Col17. In 2007, Murrell et al. (6) 
reported enamel defects in carriers of a COL17A1 null 
mutation, which was attributed to haploinsufficiency. 
Dental abnormalities have not been reported previously 
in carriers of mutations in the genes encoding LM-332. 
We report here the first enamel defects in carriers of a 
LAMA3 mutation. 
CASE REPORT
The proband was a 23-year-old woman (EB050) diagnosed with 
JEB-nH. Starting at the age of 2 months she showed generalized 
blistering and erosions that healed with atrophic scarring. She 
had dystrophic nails, and, occasionally, oral erosions. There 
was no loss of primary or secondary hair. Her entire primary 
and secondary dentition was affected with enamel hypoplasia 
and enamel pits, which were treated with direct composite 
(Fig. 1a, b). Her non-consanguineous parents and her brother 
had no signs of skin fragility. However, her 53-year-old mother 
and her 25-year-old brother also had enamel defects in their 
dentition, consisting of roughness and pits, which had led to a 
higher susceptibility to caries in both (Fig. 1c, d). The mother 
was treated with maxillary dentures and numerous restorations 
(Fig. 1c). In contrast, the father’s teeth were not affected. 
Skin biopsies in the proband and her mother were taken, and 
immunofluorescence antigen mapping was performed on non-
lesional skin. Staining of LM-332 with monoclonal antibody 
GB3 was slightly reduced in both mother and daughter, while 
staining for Col17 with monoclonal antibodies NCC-lu-226 
and 233 was normal. 
Genomic DNA of all family members was extracted from 
peripheral blood. Previous molecular analysis of COL17A1, 
LAMB3, and LAMC2 yielded no abnormalities in the pro-
band. Screening of LAMA3 (GenBank accession number 
NM_000227.3) showed a compound heterozygosity for the 
novel missense mutation c.4484C>T, and the novel nonsense 
mutation c.488delG in the proband (methods available on re-
quest). The deletion c.488delG in exon 5 creates a frameshift 
that results in a premature termination codon (p.G163DfsX30), 
and the mutation c.4484C>T in exon 33 results in a substitution 
of alanine to valine at position 1495 (p.A1495V). Proving the 
pathogenicity of the mutation p.A1495V, are 2 unrelated patients 
with JEB-nH (EB169-01 and EB173-01) in our EB cohort, who 
both carry the LAMA3 mutation p.A1495V. Patient EB169-01 
carries it together with the nonsense mutation p.R1126X, and 
patient 173-01 together with the missense mutation p.R262S 
(unpublished). 
Screening of LAMA3 in the family members of the proband 
showed that her father was heterozygous for c.4484C>T. Her 
mother and brother, showed heterozygosity for c.488delG. To 
investigate whether the enamel defects in the heterozygous 
carriers of c.488delG could be caused by a dominant-negative 
effect of an aberrant laminin α3 chain by alternatively spliced 
cDNA, nested PCRs surrounding both mutations were perfor-
med with cDNA isolated from skin biopsies from the proband 
and her mother (methods available on request). There were no 
alternatively spliced cDNA products visible on agarose gel (Fig. 
S1a, b; available from http://www.medicaljournals.se/acta/co
ntent/?doi=10.2340/00015555-1341). The PCR products were 
sequenced and cDNA of both alleles of the proband were present 
(Fig. S1c, d). The allele bearing the mutation c.488delG in the 
mother was reduced compared with the normal wild-type (Fig. 
S1c). Together with the absence of alternative spliced products 
on agarose gel, we hypothesize that this indicates that haplo-
insufficiency of LAMA3 is the cause of enamel defects in the 
mother and brother of the proband.
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Fig. 1. Features of enamel defects. (a, b) The proband (c) her mother, and (d) 
her brother had enamel defects in their dentition. (a) Rough pitted enamel is 
seen on the buccal side of the mandibular teeth, and (b) on the palatinal side 
of the maxillar teeth in the proband. The buccal side of the maxillar teeth 
are treated with direct composite. (c) The enamel defects on the labial side 
of the mandibular teeth are no longer visible due to multiple restorations in 
the mother. (d) In the brother there is typical pitted enamel in the insical area 
of the central incisors.
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DISCUSSION
Enamel is formed in 3 stages: (i) in the presecretory 
stage the ameloblasts differentiate and then the lamina 
basale, which supports the ameloblasts, disintegrates; 
(ii) in the secretory stage ameloblasts secrete enamel 
proteins that mineralize and form enamel crystals; (iii) 
in the maturation stage a lamina basale is deposited, 
adhering ameloblasts to the underlying enamel surface 
by hemidesmosomes. To harden the enamel, water and 
organic material are removed by ameloblasts (7). LM-
332 is expressed by ameloblasts in all stages of enamel 
formation (3). In the presecretory and maturation stage 
LM-332 is a part of the lamina basale. In the secretory 
stage LM-332 most likely plays a role in the adhesion 
of ameloblasts to the enamel matrix (3). In patients with 
JEB-nH the reduction in LM-332 causes detachment from 
the underlying matrix and degeneration of ameloblasts. 
This causes enamel defects, such as pitting (4, 8). The 
enamel that does form has a different chemical composi-
tion, as reduction in LM-332 can result in deficiencies in 
the junctions of ameloblasts that are important in main-
taining channels for mineral ions and cell nutrients. This 
may lead to defective mineral transport or compromised 
ameloblast metabolism (8). Teeth of patients with JEB 
have reduced mineral content and presence of serum 
albumin, which is a known inhibitor of enamel crystal 
growth (8). It is possible that there is no coping mecha-
nism that can manage the loss of one LAMA3 allele 
in this complex process of enamel formation, whereas 
these mechanisms are available in the skin (6). However, 
it remains peculiar that enamel defects have not been 
reported previously in carriers of LAMA3, LAMB3, or 
LAMC2 null mutations. Furthermore, none of the carriers 
of null mutations in LM-332 in the Dutch EB cohort 
have noted particular dental problems; however, they 
have not been examined systematically. It is possible that 
not all carriers are affected; a phenomenon also seen in 
carriers of COL17A1 null mutations (6, 9) or the enamel 
defects are so discrete that they are missed. Furthermore, 
it is possible that other factors contribute to the enamel 
defects seen in our carriers, such as the rare inherited 
enamel defects that occur in the absence of generalized 
syndromes designated as amelogenesis imperfecta (10), 
or due to environmental factors such as febrile diseases. 
However, this is less likely in our patients, considering 
the clinical dental symptoms (7). 
The enamel defects seen in the carriers of LAMA3 null 
mutations reported here are comparable to those seen in 
the carriers of missense COL17A1 mutations; although the 
carriers of COL17A1 null mutations described by Murrell 
et al. also showed horizontal ridging, a feature that was 
not present in the carriers we have described (5, 6).
In conclusion, we have reported: (i) two novel LAMA3 
mutations associated with JEB-nH; and (ii) the first car-
riers of LAMA3 null mutations to have enamel defects 
probably caused by haploinsufficiency.
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